Sel de trifluoroacétate de Leupeptin, >=90% (HPLC), microbien

Code: l2023-25mg D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

Analysis Note

Leupeptin gives multiple peaks on HPLC due to equilibria among three forms in solution. Purity determined using three main peaks. Majority of contaminating pept...


en savoir plus

Votre prix
$345.10 25MG
$414.12 inc. VAT

Non disponible en dehors du Royaume-Uni et de l'Irlande

Analysis Note

Leupeptin gives multiple peaks on HPLC due to equilibria among three forms in solution. Purity determined using three main peaks. Majority of contaminating peptide is racemized leupeptin.

Biochem/physiol Actions

Inhibitor of serine and cysteine proteases. Inhibits plasmin, trypsin, papain, calpain, and cathepsin B. Does not inhibit pepsin, cathepsins A and D, thrombin, or α-chymotrypsin. Effective concentration 10-100 µM. There have been numerous studies using leupeptin to protect against hearing loss caused by acoustic overstimulation or the ototoxic antibiotic gentamicin. (Loss of cochlear hair cells is believed to be mediated by calpain.)

Packaging

5, 10, 25, 50, 100 mg in glass bottle

assay≥90% (HPLC)
biological sourcemicrobial
formpowder
InChI keyWUHGBZVQELGOMH-FRKSIBALSA-N
InChI1S/C20H38N6O4.C2HF3O2/c1-12(2)9-16(24-14(5)28)19(30)26-17(10-13(3)4)18(29)25-15(11-27)7-6-8-23-20(21)22;3-2(4,5)1(6)7/h11-13,15-17H,6-10H2,1-5H3,(H,24,28)(H,25,29)(H,26,30)(H4,21,22,23);(H,6,7)/t15-,16-,17-;/m0./s1
Quality Level200
SMILES stringOC(=O)C(F)(F)F.CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C=O
solubilityH2O: 10 mM (Solutions are stable only a few hours. Stock solutions are stable up to 6 months at −20 °C.)
storage temp.−20°C
Code
Description
Unité de vente
Prix annoncé
Qté
L2023-10MG
Unité:10MG
Prix annoncé: $229.10
Source:Prix annoncé
L2023-1MG
Unité:1MG
Prix annoncé: $45.39
Source:Prix annoncé
L2023-50MG
Unité:50MG
Prix annoncé: $659.75
Source:Prix annoncé
L2023-5MG
Unité:5MG
Prix annoncé: $117.60
Source:Prix annoncé
Cas Number147385-61-3
Ce produit répond aux critères suivants: